The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 13, 2020

Filed:

Dec. 06, 2017
Applicant:

China National Research Institute of Food and Fermentation Industries, Beijing, CN;

Inventors:

Muyi Cai, Beijing, CN;

Huaiyu Gu, Beijing, CN;

Jun Lu, Beijing, CN;

Xingchang Pan, Beijing, CN;

Yong Ma, Beijing, CN;

Liang Chen, Beijing, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 1/12 (2006.01); C07K 1/14 (2006.01); C07K 1/36 (2006.01); C07K 5/113 (2006.01); C07K 1/34 (2006.01); C12P 21/06 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 5/1021 (2013.01); C07K 1/12 (2013.01); C07K 1/14 (2013.01); C07K 1/34 (2013.01); C07K 1/36 (2013.01); C12P 21/06 (2013.01); C12Y 304/22002 (2013.01); A61K 38/00 (2013.01);
Abstract

Provided is an active peptide for inhibiting an AMPA receptor and a preparation method and use thereof. The method for preparing the active peptide comprises the following steps: 1) soaking a salmon skin and crushing, adding water and beating, and then adjusting pH to 6.5-7.5; 2) subjecting to a first enzymolysis using a neutral protease; 3) subjecting to a second enzymolysis using papain enzyme and then inactivating enzyme; and 4) centrifuging the enzymatic hydrolysate, and then subjecting the centrifuged supernatant to membrane filtration, concentration and decoloration, to prepare the active peptide. The active peptide contains a tetrapeptide with an amino-acid sequence of Glu-Gly-Ala-Arg. The tetrapeptide has good solubility, can selectively inhibit neuronal synaptic transmission caused by an AMPA receptor, and has a significant antiepileptic effect.


Find Patent Forward Citations

Loading…